Complex Monitoring of Biochemical and Radionuclide Parameters in Patients with Metastatic Renal Cell Carcinoma during Immunotherapy

Figure 7

Correlation between a 1.6-fold increase in urea levels (±0.6) during immunotherapy and , % prior to the treatment initiation.